awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26864557-0D0BDF5E-3F74-4543-B90C-B3CA9F345B62
Q26864557-0D0BDF5E-3F74-4543-B90C-B3CA9F345B62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26864557-0D0BDF5E-3F74-4543-B90C-B3CA9F345B62
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes
P2860
Q26864557-0D0BDF5E-3F74-4543-B90C-B3CA9F345B62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26864557-0D0BDF5E-3F74-4543-B90C-B3CA9F345B62
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51cd260aa6f59fc68b97759bc42ab91c287154c7
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.